Anavex Life Sciences has announced promising outcomes from a Phase 2b/3 clinical trial for its investigational Alzheimer’s drug, blarcamesine. Conducted across multiple centers, the study
The Hatched Egg
Fresher, better, together
Fresher, better, together
Anavex Life Sciences has announced promising outcomes from a Phase 2b/3 clinical trial for its investigational Alzheimer’s drug, blarcamesine. Conducted across multiple centers, the study